Rancho Biosciences Welcomes Regeneron as the Newest Member to Its Single Cell Data Science Consortium
SAN DIEGO, March 21, 2023 (Newswire.com) - Rancho Biosciences, a leading data sciences services company, is pleased to announce that Regeneron has become the latest Member to join its Single Cell Data Science (SCDS) pre-competitive consortium, along with existing Members: BenevolentAI, Bristol Myers Squibb, Janssen Research & Development, LLC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis and Vesalius Therapeutics.
The mission of the SCDS consortium is to find a common industry standard around how single cell datasets are created and formatted by a systematic effort to develop data models and ensure that public data are curated in a consistent way. Due to the undeniable impact of single cell transcriptomics technology on drug discovery, there continues to be an exponential growth in the use of single cell sequencing methods by pharmaceutical companies. The availability of ever-increasing amounts of single cell datasets in the public domain allows pharmaceutical companies to dramatically expand their universe of single cell experiments over those generated internally. Leveraging this vast public data lake by finding, downloading and curating single cell data is highly laborious and time consuming compared to the resources for collectively analyzing data by scientists to gain value for biomedical research.
In Year 1, the SCDS consortium delivered a Data Tracker portal, and a 4-entity, deep data model around which 115 analysis-ready, harmonized datasets were released to Members. Now in Year 2, Members will continue to prioritize the deliverables and receive an ongoing stream of harmonized single cell datasets. In addition, there will be increased emphasis on cell type annotation, the creation of an SCDS Reference Atlas and evaluating multi-modal datasets. Under this shared cost model, these can be delivered at much higher throughput than one single company could achieve and much more cost-effectively. New Members are welcome.
Founded in 2012, Rancho Biosciences is a privately held company offering services for data curation, management and analysis for companies engaged in pharmaceutical research and development. Its clients include top 20 pharma and biotech companies, research foundations, government labs and academic groups.
For more information about Rancho and the SCDS consortium, contact:
Andy Hope, PhD
Source: Rancho BioSciences, LLC